Klea Holding (ALKLH) Fair Value & Analysis
Healthcare · FR · Market cap €60.2M
Fair value as of: Jun 26, 2026
Analysis
Klea Holding (ALKLH) currently trades at €0.1848, while our model-based Fair Value estimate is €0.0800 — implying the stock looks roughly 56.7% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. Additionally, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 2007 and is headquartered in Paris, France.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Klea Holding (ALKLH) undervalued?
What is the fair value of ALKLH?
What is the quality score of ALKLH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.